Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury.
about
Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injuryStatins and cerebral hemodynamicsMitochondrial targets for pharmacological intervention in human diseaseNeuroprotection for traumatic brain injuryCerebral blood flow changes after brain injury in human amyloid-beta knock-in micePHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLDWhat's New in Traumatic Brain Injury: Update on Tracking, Monitoring and TreatmentComparison of the effect of minocycline and simvastatin on functional recovery and gene expression in a rat traumatic brain injury model.Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair.Female gonadal hormone effects on microglial activation and functional outcomes in a mouse model of moderate traumatic brain injury.Angiogenesis, neurogenesis and brain recovery of function following injuryNeurorestorative effect of urinary bladder matrix-mediated neural stem cell transplantation following traumatic brain injury in rats.Simvastatin combined with antioxidant attenuates the cerebral vascular endothelial inflammatory response in a rat traumatic brain injury.Acute administration of catalase targeted to ICAM-1 attenuates neuropathology in experimental traumatic brain injury.Impact of statins on cognitive deficits in adult male rodents after traumatic brain injury: a systematic review.Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies2',3'-cAMP, 3'-AMP, 2'-AMP and adenosine inhibit TNF-α and CXCL10 production from activated primary murine microglia via A2A receptors.Chronic pravastatin but not atorvastatin treatment impairs cognitive function in two rodent models of learning and memoryBiologic and plastic effects of experimental traumatic brain injury treatment paradigms and their relevance to clinical rehabilitation.Statins and brain dysfunction: a hypothesis to reduce the burden of cognitive impairment in patients who are critically illIsoprenoids and related pharmacological interventions: potential application in Alzheimer's disease.Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury.Delayed expression of cell cycle proteins contributes to astroglial scar formation and chronic inflammation after rat spinal cord contusionSelective gelatinase inhibitor neuroprotective agents cross the blood-brain barrierRosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial.HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in ratsStatin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death.Differential effects of simvastatin and pravastatin on expression of Alzheimer's disease-related genes in human astrocytes and neuronal cells.Statins in traumatic brain injury.The first 83 and the next 83: perspectives on neurotoxicologyAdministration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact.Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.Statin use and risk of delirium in the critically ill.Mechanisms and clinical evidence of the pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in central nervous system disorders: a comprehensive review.Further understanding of cerebral autoregulation at the bedside: possible implications for future therapy.Treatment of traumatic brain injury with anti-inflammatory drugs.GSNO promotes functional recovery in experimental TBI by stabilizing HIF-1α.Induction of angiogenesis and modulation of vascular endothelial growth factor receptor-2 by simvastatin after traumatic brain injury.Combination therapies for traumatic brain injury: prospective considerations.Effect of pregabalin in preventing secondary damage in traumatic brain injury: an experimental study.
P2860
Q21245237-5D350E5B-4B5C-4C4C-9D10-807231D45EDDQ26822457-FD008D54-492D-4319-ADC2-2EFE45164A76Q26824514-D7DADA6E-7CF8-44C8-8456-9A5D70C22519Q26824808-B58FDAB9-18FB-4949-A584-6D374F62631BQ30412815-7B58A63C-7D68-4633-9394-4A06E35287A0Q30474822-85C48D1C-20F4-42A2-B93F-9CD30B95A5F5Q30959630-537F354F-E38D-49DE-B026-CA6E99745C36Q33576429-BA0770E3-68DA-4720-8267-7CEC29203C36Q33610240-23B447C6-739D-4162-B1D4-566D2E95BA7FQ33634989-C85A23FC-EEF8-428D-9304-4D2DE18F2BFEQ33718009-F027D21A-71A2-441D-8403-3DFB77482345Q33724891-24A383A5-814C-40CB-9181-A2379391D4FCQ33809964-AA1EB1DF-99A2-4410-AF13-BCEC4589296AQ33812816-9266884C-D4AE-48EF-8B63-6CC0815A2197Q34054471-35C3AC77-ED0D-40AB-A5C9-3D2F9C24B0E6Q34147023-A06CEC7A-7523-4502-85EC-B8232071328BQ34674936-C90E9859-8C52-4AA2-9AA9-65D3BD9D645EQ34990621-FF9E4A9C-7240-4BEA-9312-03F6798730B7Q35136513-E8615AA2-8253-4270-B60D-4E526FF5D39FQ35201872-81344DAD-FFE2-4708-B44E-45EFE98BD500Q35634151-B26C4B89-137A-4660-9B3A-34091CF736B3Q35842329-5E85BC7E-E01B-47DD-BBD9-45D3FAE6ABFBQ36136722-F251E643-CEBF-43BF-A9AC-0DA80F6B413BQ36326852-11E429A4-644E-4162-9DA4-06D6CE8243DFQ36689726-E75FB486-798B-4E6D-B9E1-F1EFF8D46322Q37120410-E42D2DC1-9CF7-4B79-A165-9C300B138BCCQ37243450-0BA68559-60BA-4E34-9DE8-8539DB4A367BQ37337494-BA12091E-CA0E-4DE2-ADC8-34D6C602375FQ37374151-909349C2-C84A-42B3-8404-24DBE8F18678Q37387272-6ACB9875-1836-4D53-AA07-377C62C14D71Q37420533-0BBC50D4-6A31-48DB-A5AC-2D25B64EC588Q37508249-A412FC36-526E-4CC3-B653-0085DDA7A212Q37682627-136E7A7C-C71E-40CA-85BE-EA8321BB6852Q38020536-97F75BB1-C458-43FB-9A36-89E01EE0BDB5Q38329798-C82EAC66-32E6-4621-83C0-A6D51893160EQ38538072-8F9E74F8-B1F3-4836-9EBC-2DA1294ED225Q39250264-A91E9A9D-4BC5-43CA-AD71-6AA6AA0C3D68Q39595122-1B9CDBF4-7B10-454B-BCFE-65FC70AF2765Q42616360-B533C572-DE67-4340-911A-6C924568F984Q42690982-C6198EE8-058F-44FF-AC90-5BDBE5D40D3B
P2860
Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Simvastatin and atorvastatin i ...... mental traumatic brain injury.
@en
Simvastatin and atorvastatin i ...... mental traumatic brain injury.
@nl
type
label
Simvastatin and atorvastatin i ...... mental traumatic brain injury.
@en
Simvastatin and atorvastatin i ...... mental traumatic brain injury.
@nl
prefLabel
Simvastatin and atorvastatin i ...... mental traumatic brain injury.
@en
Simvastatin and atorvastatin i ...... mental traumatic brain injury.
@nl
P2093
P1476
Simvastatin and atorvastatin i ...... mental traumatic brain injury.
@en
P2093
Brian Mace
Daniel T Laskowitz
David S Warner
Haichen Wang
Hyuk-Jun Yang
John R Lynch
Pingping Song
Robert B Yates
P356
10.1016/J.EXPNEUROL.2007.03.031
P407
P50
P577
2007-04-27T00:00:00Z